In response to a recent suggestion from Michael about how to verify evidence of synthetic bio-nanotechnology in pharmaceutical products, I find that it's worth taking a step back and examining the broader context and implications of such an approach.
Yep. We know enough. There is nothing to prevent Michael following on behind. It's by no means an ignoble position.
But if David wants to follow his nose, well it's done pretty well so far.
I don't see any benefit from a party line here.